Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment

OBJECTIVES: Among autoimmune diseases, rheumatoid arthritis (RA) is the most common chronic inflammatory disease of the joints. Its pathogenesis is still not fully understood, but the gained knowledge has contributed to the development of modern treatment. The introduction of biological therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalik, Krzysztof, Węgierska, Małgorzata, Barczyńska, Tacjana, Jeka, Sławomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330685/
https://www.ncbi.nlm.nih.gov/pubmed/30647479
http://dx.doi.org/10.5114/reum.2018.80710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330685/
https://www.ncbi.nlm.nih.gov/pubmed/30647479
http://dx.doi.org/10.5114/reum.2018.80710

Ejemplares similares